BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 16540796)

  • 1. Decreased peroxisome proliferator activated receptor alpha is associated with bile duct injury in cystic fibrosis transmembrane conductance regulator-/- mice.
    Pall H; Zaman MM; Andersson C; Freedman SD
    J Pediatr Gastroenterol Nutr; 2006 Mar; 42(3):275-81. PubMed ID: 16540796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of colitis in cftr-/- mice results in bile duct injury.
    Blanco PG; Zaman MM; Junaidi O; Sheth S; Yantiss RK; Nasser IA; Freedman SD
    Am J Physiol Gastrointest Liver Physiol; 2004 Aug; 287(2):G491-6. PubMed ID: 15064232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased expression of peroxisome proliferator activated receptor gamma in cftr-/- mice.
    Ollero M; Junaidi O; Zaman MM; Tzameli I; Ferrando AA; Andersson C; Blanco PG; Bialecki E; Freedman SD
    J Cell Physiol; 2004 Aug; 200(2):235-44. PubMed ID: 15174093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cystic fibrosis transmembrane conductance regulator deficiency exacerbates islet cell dysfunction after beta-cell injury.
    Stalvey MS; Muller C; Schatz DA; Wasserfall CH; Campbell-Thompson ML; Theriaque DW; Flotte TR; Atkinson MA
    Diabetes; 2006 Jul; 55(7):1939-45. PubMed ID: 16804061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term docosahexaenoic acid therapy in a congenic murine model of cystic fibrosis.
    Beharry S; Ackerley C; Corey M; Kent G; Heng YM; Christensen H; Luk C; Yantiss RK; Nasser IA; Zaman M; Freedman SD; Durie PR
    Am J Physiol Gastrointest Liver Physiol; 2007 Mar; 292(3):G839-48. PubMed ID: 17095751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced intestinal inflammation induced by dextran sodium sulfate in interleukin-6-deficient mice.
    Naito Y; Takagi T; Uchiyama K; Kuroda M; Kokura S; Ichikawa H; Yanagisawa R; Inoue K; Takano H; Satoh M; Yoshida N; Okanoue T; Yoshikawa T
    Int J Mol Med; 2004 Aug; 14(2):191-6. PubMed ID: 15254764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CFTR dysfunction predisposes to fibrotic liver disease in a murine model.
    Martin CR; Zaman MM; Ketwaroo GA; Bhutta AQ; Coronel E; Popov Y; Schuppan D; Freedman SD
    Am J Physiol Gastrointest Liver Physiol; 2012 Aug; 303(4):G474-81. PubMed ID: 22679000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of cystic fibrosis transmembrane conductance regulator in liver tissue from patients with cystic fibrosis.
    Kinnman N; Lindblad A; Housset C; Buentke E; Scheynius A; Strandvik B; Hultcrantz R
    Hepatology; 2000 Aug; 32(2):334-40. PubMed ID: 10915740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted inactivation of cystic fibrosis transmembrane conductance regulator chloride channel gene prevents ischemic preconditioning in isolated mouse heart.
    Chen H; Liu LL; Ye LL; McGuckin C; Tamowski S; Scowen P; Tian H; Murray K; Hatton WJ; Duan D
    Circulation; 2004 Aug; 110(6):700-4. PubMed ID: 15289377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgenic expression of mutant peroxisome proliferator-activated receptor gamma in liver precipitates fasting-induced steatosis but protects against high-fat diet-induced steatosis in mice.
    Tanaka T; Masuzaki H; Ebihara K; Ogawa Y; Yasue S; Yukioka H; Chusho H; Miyanaga F; Miyazawa T; Fujimoto M; Kusakabe T; Kobayashi N; Hayashi T; Hosoda K; Nakao K
    Metabolism; 2005 Nov; 54(11):1490-8. PubMed ID: 16253638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ursodeoxycholate modulates bile flow and bile salt pool independently from the cystic fibrosis transmembrane regulator (Cftr) in mice.
    Bodewes FA; Wouthuyzen-Bakker M; Bijvelds MJ; Havinga R; de Jonge HR; Verkade HJ
    Am J Physiol Gastrointest Liver Physiol; 2012 May; 302(9):G1035-42. PubMed ID: 22301109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered eicosanoid metabolism in the cystic fibrosis mouse small intestine.
    De Lisle RC; Meldi L; Flynn M; Jansson K
    J Pediatr Gastroenterol Nutr; 2008 Oct; 47(4):406-16. PubMed ID: 18852632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostacyclin-induced peroxisome proliferator-activated receptor-alpha translocation attenuates NF-kappaB and TNF-alpha activation after renal ischemia-reperfusion injury.
    Chen HH; Chen TW; Lin H
    Am J Physiol Renal Physiol; 2009 Oct; 297(4):F1109-18. PubMed ID: 19640904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cystic fibrosis is associated with a defect in apical receptor-mediated endocytosis in mouse and human kidney.
    Jouret F; Bernard A; Hermans C; Dom G; Terryn S; Leal T; Lebecque P; Cassiman JJ; Scholte BJ; de Jonge HR; Courtoy PJ; Devuyst O
    J Am Soc Nephrol; 2007 Mar; 18(3):707-18. PubMed ID: 17287432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic cytochrome P450 gene regulation during endotoxin-induced inflammation in nuclear receptor knockout mice.
    Richardson TA; Morgan ET
    J Pharmacol Exp Ther; 2005 Aug; 314(2):703-9. PubMed ID: 15860574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of experimental colitis by intestinal mononuclear phagocytes.
    Qualls JE; Kaplan AM; van Rooijen N; Cohen DA
    J Leukoc Biol; 2006 Oct; 80(4):802-15. PubMed ID: 16888083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormally up-regulated cystic fibrosis transmembrane conductance regulator expression and uterine fluid accumulation contribute to Chlamydia trachomatis-induced female infertility.
    He Q; Tsang LL; Ajonuma LC; Chan HC
    Fertil Steril; 2010 May; 93(8):2608-14. PubMed ID: 20227074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of peroxisome proliferator-activated receptor-alpha (PPARalpha) in bezafibrate-induced hepatocarcinogenesis and cholestasis.
    Hays T; Rusyn I; Burns AM; Kennett MJ; Ward JM; Gonzalez FJ; Peters JM
    Carcinogenesis; 2005 Jan; 26(1):219-27. PubMed ID: 15447978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferator-activated receptor-alpha and -gamma mRNA levels are reduced in chronic hepatitis C with steatosis and genotype 3 infection.
    de Gottardi A; Pazienza V; Pugnale P; Bruttin F; Rubbia-Brandt L; Juge-Aubry CE; Meier CA; Hadengue A; Negro F
    Aliment Pharmacol Ther; 2006 Jan; 23(1):107-14. PubMed ID: 16393287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptor alpha (PPAR alpha) down-regulation in cystic fibrosis lymphocytes.
    Reynders V; Loitsch S; Steinhauer C; Wagner T; Steinhilber D; Bargon J
    Respir Res; 2006 Jul; 7(1):104. PubMed ID: 16875506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.